These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36411396)
81. Ethnic-specific obesity cutoffs for diabetes risk: cross-sectional study of 490,288 UK biobank participants. Ntuk UE; Gill JM; Mackay DF; Sattar N; Pell JP Diabetes Care; 2014 Sep; 37(9):2500-7. PubMed ID: 24974975 [TBL] [Abstract][Full Text] [Related]
82. Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening. Ginde AA; Cagliero E; Nathan DM; Camargo CA Acad Emerg Med; 2008 Dec; 15(12):1241-7. PubMed ID: 18785943 [TBL] [Abstract][Full Text] [Related]
83. Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study. Rodgers LR; Hill AV; Dennis JM; Craig Z; May B; Hattersley AT; McDonald TJ; Andrews RC; Jones A; Shields BM BMC Med; 2021 Aug; 19(1):184. PubMed ID: 34412655 [TBL] [Abstract][Full Text] [Related]
84. Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors' Facility Residents. Featherstone T; Eurich DT; Simpson SH Value Health; 2017 Mar; 20(3):329-335. PubMed ID: 28292477 [TBL] [Abstract][Full Text] [Related]
85. Prevalence of undiagnosed and suboptimally controlled diabetes by point-of-care HbA1C in unselected emergency department patients. Menchine MD; Arora S; Camargo CA; Ginde AA Acad Emerg Med; 2011 Mar; 18(3):326-9. PubMed ID: 21362098 [TBL] [Abstract][Full Text] [Related]
86. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147 [TBL] [Abstract][Full Text] [Related]
87. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lean MEJ; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Welsh P; Kean S; Ford I; McConnachie A; Messow CM; Sattar N; Taylor R Lancet Diabetes Endocrinol; 2019 May; 7(5):344-355. PubMed ID: 30852132 [TBL] [Abstract][Full Text] [Related]
88. Expanding Diabetes Screening to Identify Undiagnosed Cases Among Emergency Department Patients. Lee DC; Reddy H; Koziatek CA; Klein N; Chitnis A; Creary K; Francois G; Akindutire O; Femia R; Caldwell R West J Emerg Med; 2023 Sep; 24(5):962-966. PubMed ID: 37788038 [No Abstract] [Full Text] [Related]
89. Identifying top ten predictors of type 2 diabetes through machine learning analysis of UK Biobank data. Lugner M; Rawshani A; Helleryd E; Eliasson B Sci Rep; 2024 Jan; 14(1):2102. PubMed ID: 38267466 [TBL] [Abstract][Full Text] [Related]
90. UK Biobank: a globally important resource for cancer research. Conroy MC; Lacey B; Bešević J; Omiyale W; Feng Q; Effingham M; Sellers J; Sheard S; Pancholi M; Gregory G; Busby J; Collins R; Allen NE Br J Cancer; 2023 Feb; 128(4):519-527. PubMed ID: 36402876 [TBL] [Abstract][Full Text] [Related]
91. A deep learning transformer model predicts high rates of undiagnosed rare disease in large electronic health systems. Jordan DM; Vy HMT; Do R medRxiv; 2023 Dec; ():. PubMed ID: 38196638 [TBL] [Abstract][Full Text] [Related]
92. Diurnal Physical Activity Patterns across Ages in a Large UK Based Cohort: The UK Biobank Study. Wrobel J; Muschelli J; Leroux A Sensors (Basel); 2021 Feb; 21(4):. PubMed ID: 33672201 [TBL] [Abstract][Full Text] [Related]
93. Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK Biobank. Allen NE; Arnold M; Parish S; Hill M; Sheard S; Callen H; Fry D; Moffat S; Gordon M; Welsh S; Elliott P; Collins R Wellcome Open Res; 2020; 5():222. PubMed ID: 33364437 [No Abstract] [Full Text] [Related]
94. Dental teams could detect undiagnosed diabetes in more than one million people with new care pathway. Br Dent J; 2024 Oct; 237(7):527. PubMed ID: 39394285 [No Abstract] [Full Text] [Related]
95. Cause-specific death in adults with type 1 diabetes and type 2 diabetes: Insights from the UK Biobank. Ostrominski JW; Cho SMJ; Vaduganathan M; Honigberg MC Diabetes Obes Metab; 2024 Oct; ():. PubMed ID: 39402726 [No Abstract] [Full Text] [Related]
96. Spotting Undiagnosed Significant Liver Fibrosis in the General Population: Impact on Subsequent Clinical Care. Peng N; Wang MY; Song SJ; Yip TC Clin Mol Hepatol; 2024 Sep; ():. PubMed ID: 39228070 [No Abstract] [Full Text] [Related]
97. Association of triglyceride-glucose index and its combination with adiposity-related indices with the incidence of myocardial infarction: a cohort study from the UK Biobank. Zhou J; Huang H; Huang H; Peng J; Chen W; Chen F; Tang Y; Li Q; Xiong Y; Zhou L Int J Obes (Lond); 2024 Oct; 48(10):1498-1505. PubMed ID: 39143294 [TBL] [Abstract][Full Text] [Related]
98. Association of prior outpatient diabetes screening with cardiovascular events and mortality among people with incident diabetes: a population-based cohort study. Ke C; Chu A; Shah BR; Tobe S; Tu K; Fang J; Vaid H; Liu P; Cader A; Lee DS Cardiovasc Diabetol; 2023 Aug; 22(1):227. PubMed ID: 37641086 [TBL] [Abstract][Full Text] [Related]
99. HbA Young KG; McGovern AP; Barroso I; Hattersley AT; Jones AG; Shields BM; Thomas NJ; Dennis JM Diabetologia; 2023 Aug; 66(8):1578-1579. PubMed ID: 37272950 [No Abstract] [Full Text] [Related]